Travtec, a packaging line solutions specialist, has opened a second facility close to its Leigh, Lancashire headquarters. This move is part of an investment to expand the company?s operations to meet continuing demand for its systems, particularly as the pharmaceutical industry prepares for the current and forthcoming track and trace legislation, including the 2017 European Falsified Medicines Directive.
Travtec, a packaging line solutions specialist, has opened a second facility close to its Leigh, Lancashire headquarters. This move is part of an investment to expand the company’s operations to meet continuing demand for its systems, particularly as the pharmaceutical industry prepares for the current and forthcoming track and trace legislation, including the 2017 European Falsified Medicines Directive.
The new 150 m2 offices will house Travtec’s administrative support services, allowing its original building to increase its operational space by 200 m2. Travtec will be able to further expand its product offering, with the introduction of the full range of Lixis inspection equipment, including a blister vision system and pinhole detector.
Travtec specializes in the design and manufacture of product handling systems for a wide range of industries, including GSK, AstraZeneca, Merck, Bristol-Myers Squibb and Johnson & Johnson. The company’s product handling, coding and inspection systems are designed to complement inkjet printers, labellers, print and apply and thermal transfer equipment. Travtec works in partnership with OEMs to develop innovative new applications for both existing products and those under development. Travtec’s subsidiary company, Sunala, is the UK and Eire distributor for the Wolke m600 thermal inkjet printer for the pharmaceutical sector.
“This is an important milestone in the continuing growth of Travtec, enabling us to keep pace with customer demands throughout Europe,” commented Travtec managing director, Harry Thomason, in a press statement. “The new facilities and additional space will help to ensure we continue to devise and bring to market quickly innovative solutions that help our customers increase efficiencies.”
Source: Travtec
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.